Primary Site >> Esophagus Cancer

Gene >> MET

  • 1993
  • 1994
  • 1995
  • 2002
  • 2009
  • 2010
  • 2011
  • 2013
  • 2014
  • 2016
  • 2017
  • 2018
Ref: [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers].
PMID: 8094950
Ref: [Metastasis-related genes].
PMID: 7526801
Ref: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis.
PMID: 7889467
Ref: Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer.
PMID: 11857377
Ref: Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
PMID: 19406933
Ref: [Apoptosis effects on human esophageal cancer cells by soyasaponin Bb and its machanism].
PMID: 20726234
Ref: Prognostic significance of differentially expressed miRNAs in esophageal cancer.
PMID: 20309880
Ref: Targeted therapies with chemoradiation in esophageal cancer: development and future directions.
PMID: 23207045
Ref: Esophageal carcinoma: are modern targeted therapies shaking the rock?
PMID: 23680713
Ref: Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.
PMID: 24490044
Ref: MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
PMID: 24742823
Ref: Targeted therapy in esophageal cancer.
PMID: 26895097
Ref: C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
PMID: 27636117
Ref: Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met.
PMID: 28529610
Ref: HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
PMID: 29223420